Skip to main content
logo
Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
7.98
+0.02 (0.25%)
At close: Sep 28, 2026, 4:00 PM EDT
8.13
+0.15 (1.88%)
Pre-market: Sep 29, 2026, 7:21 AM EDT

Harvard Bioscience Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
87.8186.5594.14112.25113.34118.9
Revenue Growth
-1.06%-8.06%-16.14%-0.96%-4.68%16.46%
Gross Profit
51.0749.9154.8166.3962.2967.65
Operating Income
1.971.5-4.722.5-5.193.69
Net Income
-10.41-56.7-12.41-3.42-9.52-0.29
Earnings Per Share
-2.35-12.80-2.85-0.81-2.30-0.10
EPS Growth
------

Revenue by Geography
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
38.7938.9741.7448.2149.9149.83
Americas - Other
3.73.233.63.52--
Europe, Middle East and Africa
27.3526.7128.4133.28--
China
11.6710.9713.318.4916.3913.5
Asia - Other
6.36.687.18.77--
Total
87.8186.5594.14112.25113.34118.9

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.58.614.117.784.517.82
Total Debt
44.2144.2844.5942.9754.2456.96
Net Cash (Debt)
-37.7-35.66-40.49-35.19-49.73-49.14
Net Cash Growth
------
Net Cash Per Share
-8.43-8.03-9.30-8.30-12.01-12.18

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
0.656.731.4414.031.151.26
Capital Expenditures
-1.77-1.26-2.64-1.79-1.59-1.2
Free Cash Flow
-1.125.47-1.212.24-0.440.07
Free Cash Flow Growth
------99.18%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
58.16%57.67%58.22%59.15%54.96%56.90%
Operating Margin
2.25%1.73%-5.01%2.22%-4.58%3.10%
Pretax Margin
-12.00%-66.30%-12.39%-2.28%-8.10%-0.12%
Profit Margin
-11.86%-65.51%-13.18%-3.04%-8.40%-0.24%
FCF Margin
-1.27%6.32%-1.28%10.90%-0.39%0.06%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
44.337.8717.5823.2617.8722.03
P/FCF Ratio
-5.45-18.66-4294.24
PS Ratio
0.410.340.982.041.022.42